Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine adjunctive to lithium or valproate in acute mania
NCT00145470Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Asenapine with Placebo (2 arms). Primary endpoint: Least Squares Mean Change From Baseline in Young-Mania Rating Scale (Y-MRS) Score at Day 21. Started Jun 2005; status: completed.
02
Drugs
asenapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00145470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145470.